newsfilter
← Latest News
Business Wire·

Epizyme to Present New Data from Its Oncology Portfolio at 2021 American Society of Hematology Annual Meeting

Epizyme, Inc. (NASDAQ:EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering transformative therapies against novel epigenetic targets, today announced that new data from across its oncology portfolio will be pre